These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6372069)

  • 21. A controlled trial of combination chemotherapy with 5-FU and BCNU in pancreatic cancer.
    Andersen JR; Friis-Möller A; Hancke S; Röder O; Steen J; Baden H
    Scand J Gastroenterol; 1981; 16(8):973-5. PubMed ID: 7038842
    [No Abstract]   [Full Text] [Related]  

  • 22. Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities.
    Buckner JC; Gesme D; O'Fallon JR; Hammack JE; Stafford S; Brown PD; Hawkins R; Scheithauer BW; Erickson BJ; Levitt R; Shaw EG; Jenkins R
    J Clin Oncol; 2003 Jan; 21(2):251-5. PubMed ID: 12525516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy versus chemotherapy plus irradiation in limited small cell lung cancer. Results of a controlled trial with 5 years follow-up.
    Osterlind K; Hansen HH; Hansen HS; Dombernowsky P; Hansen M; Rørth M
    Br J Cancer; 1986 Jul; 54(1):7-17. PubMed ID: 3015184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastatic colorectal carcinoma. A prospective randomized trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep).
    Kemeny N; Yagoda A; Braun D
    Cancer; 1983 Jan; 51(1):20-4. PubMed ID: 6217886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report.
    Takita H; Marabella PC; Edgerton F; Rizzo D
    Cancer Treat Rep; 1979 Jan; 63(1):29-33. PubMed ID: 369692
    [No Abstract]   [Full Text] [Related]  

  • 26. Ifosfamide plus 5-fluorouracil for treatment of adenocarcinoma of the pancreas.
    Loehrer PJ; Williams SD; Nichols CR
    Cancer Treat Rep; 1987 Nov; 71(11):1115-6. PubMed ID: 3119208
    [No Abstract]   [Full Text] [Related]  

  • 27. Chemotherapy of gastric and pancreatic carcinoma: a controlled evaluation of combinations of 5-fluorouracil with nitrosoureas and "lactones".
    Moertel CG; Engstrom P; Lavin PT; Gelber RD; Carbone PP
    Surgery; 1979 May; 85(5):509-13. PubMed ID: 155322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation therapy combined with Adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma. Gastrointestinal Tumor Study Group.
    Cancer; 1985 Dec; 56(11):2563-8. PubMed ID: 2864997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy of malignant glioma with CCNU alone and CCNU combined with vincristine sulfate and procarbazine hydrochloride.
    Shapiro WR; Young DF
    Trans Am Neurol Assoc; 1976; 101():217-20. PubMed ID: 1028239
    [No Abstract]   [Full Text] [Related]  

  • 30. Procarbazine, lomustine, vincristine combination may be effective in adult medulloblastoma patients with systemic metastases.
    Cakar M; Aksoy S; Kilickap S; Harputluoglu H; Erman M
    J Neurooncol; 2005 Nov; 75(2):233-4. PubMed ID: 16132496
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of adenocarcinoma with combinations of cyclopjosphamide (NSC-26271), vincristine (NSC-67574), and 5-fluorouracil (NSC-19893).
    Tucker WG; Talley RW; Lane M; Bonnet JD
    Cancer Chemother Rep; 1975; 59(2 Pt 1):425-7. PubMed ID: 1097101
    [No Abstract]   [Full Text] [Related]  

  • 32. FAM chemotherapy +/- aminoglutethimide in the treatment of pancreatic carcinoma.
    Lipton A; Harvey HA; Santen RJ; Stryker JA; Barnes SG; Walker BK; Dixon RH; Givant EM; Bartholomew MJ; Nadjafi C
    Eur J Surg Oncol; 1990 Feb; 16(1):12-4. PubMed ID: 2307239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
    Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
    Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase.
    Cornetta K; Croop J; Dropcho E; Abonour R; Kieran MW; Kreissman S; Reeves L; Erickson LC; Williams DA
    Cancer Gene Ther; 2006 Sep; 13(9):886-95. PubMed ID: 16645619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination chemotherapy in metastatic or recurrent non-small cell bronchogenic carcinoma. 5-year results.
    Ojala A; Nikkanen VN; Paloheimo S; Palojoki A; Thölix E
    Strahlentherapie; 1983 Dec; 159(12):775-7. PubMed ID: 6364459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination chemotherapy with three marginally effective agents, CCNU, vincristine, and bleomycin, in the treatment of stage III melanoma.
    De Wasch G; Bernheim J; Michel J; Lejeune F; Kenis Y
    Cancer Treat Rep; 1976 Sep; 60(9):1273-6. PubMed ID: 65222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
    Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD
    Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU.
    Macdonald JS; Kisner DF; Smythe T; Woolley PV; Smith L; Schein PS
    Cancer Treat Rep; 1976 Nov; 60(11):1597-600. PubMed ID: 1021233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-analysis of Modified FOLFIRINOX Regimens for Patients With Metastatic Pancreatic Cancer.
    Usón Junior PLS; Rother ET; Maluf FC; Bugano DDG
    Clin Colorectal Cancer; 2018 Sep; 17(3):187-197. PubMed ID: 29615310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C for non-resectable pancreatic and biliary carcinoma: multicenter randomized trial.
    Takada T; Nimura Y; Katoh H; Nagakawa T; Nakayama T; Matsushiro T; Amano H; Wada K
    Hepatogastroenterology; 1998; 45(24):2020-6. PubMed ID: 9951857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.